FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W104393772> ?p ?o ?g. }

• W104393772 endingPage "201" @default.
• W104393772 startingPage "193" @default.
• W104393772 abstract "The BLAST-AHF (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure) study is designed to test the efficacy and safety of TRV027, a novel biased ligand of the angiotensin-2 type 1 receptor, in patients with acute heart failure (AHF). AHF remains a major public health problem, and no currently-available therapies have been shown to favorably affect outcomes. TRV027 is a novel biased ligand of the angiotensin-2 type 1 receptor that antagonizes angiotensin-stimulated G-protein activation while stimulating β-arrestin. In animal models, these effects reduce afterload while increasing cardiac performance and maintaining stroke volume. In initial human studies, TRV027 appears to be hemodynamically active primarily in patients with activation of the renin-angiotensin-aldosterone system, a potentially attractive profile for an AHF therapeutic. BLAST-AHF is an international prospective, randomized, phase IIb, dose-ranging study that will randomize up to 500 AHF patients with systolic blood pressure ≥120 mm Hg and ≤200 mm Hg within 24 h of initial presentation to 1 of 3 doses of intravenous TRV027 (1, 5, or 25 mg/h) or matching placebo (1:1:1:1) for at least 48 h and up to 96 h. The primary endpoint is a composite of 5 clinical endpoints (dyspnea, worsening heart failure, length of hospital stay, 30-day rehospitalization, and 30-day mortality) combined using an average z-score. Secondary endpoints will include the assessment of dyspnea and change in amino-terminal pro-B-type natriuretic peptide. The BLAST-AHF study will assess the efficacy and safety of a novel biased ligand of the angiotensin-2 type 1 receptor in AHF." @default.
• W104393772 created "2016-06-24" @default.
• W104393772 creator A5006527198 @default.
• W104393772 creator A5015042720 @default.
• W104393772 creator A5017097200 @default.
• W104393772 creator A5017272571 @default.
• W104393772 creator A5019809785 @default.
• W104393772 creator A5022076272 @default.
• W104393772 creator A5023320363 @default.
• W104393772 creator A5053760015 @default.
• W104393772 creator A5054668121 @default.
• W104393772 creator A5066769664 @default.
• W104393772 creator A5074566771 @default.
• W104393772 creator A5075195777 @default.
• W104393772 creator A5079420772 @default.
• W104393772 creator A5089784577 @default.
• W104393772 creator A5091675945 @default.
• W104393772 date "2015-03-01" @default.
• W104393772 modified "2023-10-03" @default.
• W104393772 title "Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor" @default.
• W104393772 cites W1966117168 @default.
• W104393772 cites W1971057214 @default.
• W104393772 cites W1974661897 @default.
• W104393772 cites W1978284123 @default.
• W104393772 cites W2006145911 @default.
• W104393772 cites W2031363100 @default.
• W104393772 cites W2039116306 @default.
• W104393772 cites W2043084865 @default.
• W104393772 cites W2048664109 @default.
• W104393772 cites W2052491256 @default.
• W104393772 cites W2054183115 @default.
• W104393772 cites W2055123579 @default.
• W104393772 cites W2069722675 @default.
• W104393772 cites W2071907783 @default.
• W104393772 cites W2072857975 @default.
• W104393772 cites W2091928448 @default.
• W104393772 cites W2096355643 @default.
• W104393772 cites W2099817260 @default.
• W104393772 cites W2105079567 @default.
• W104393772 cites W2105084079 @default.
• W104393772 cites W2130632774 @default.
• W104393772 cites W2134462651 @default.
• W104393772 cites W2138839431 @default.
• W104393772 cites W2143227312 @default.
• W104393772 cites W2144049010 @default.
• W104393772 cites W2147196684 @default.
• W104393772 cites W2147588039 @default.
• W104393772 cites W2148910374 @default.
• W104393772 cites W2151301327 @default.
• W104393772 cites W2152334831 @default.
• W104393772 cites W2160489474 @default.
• W104393772 cites W2168507847 @default.
• W104393772 cites W2326132384 @default.
• W104393772 cites W2335312575 @default.
• W104393772 doi "https://doi.org/10.1016/j.jchf.2014.09.008" @default.
• W104393772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25650371" @default.
• W104393772 hasPublicationYear "2015" @default.
• W104393772 type Work @default.
• W104393772 sameAs 104393772 @default.
• W104393772 citedByCount "67" @default.
• W104393772 countsByYear W1043937722015 @default.
• W104393772 countsByYear W1043937722016 @default.
• W104393772 countsByYear W1043937722017 @default.
• W104393772 countsByYear W1043937722018 @default.
• W104393772 countsByYear W1043937722019 @default.
• W104393772 countsByYear W1043937722020 @default.
• W104393772 countsByYear W1043937722021 @default.
• W104393772 countsByYear W1043937722022 @default.
• W104393772 countsByYear W1043937722023 @default.
• W104393772 crossrefType "journal-article" @default.
• W104393772 hasAuthorship W104393772A5006527198 @default.
• W104393772 hasAuthorship W104393772A5015042720 @default.
• W104393772 hasAuthorship W104393772A5017097200 @default.
• W104393772 hasAuthorship W104393772A5017272571 @default.
• W104393772 hasAuthorship W104393772A5019809785 @default.
• W104393772 hasAuthorship W104393772A5022076272 @default.
• W104393772 hasAuthorship W104393772A5023320363 @default.
• W104393772 hasAuthorship W104393772A5053760015 @default.
• W104393772 hasAuthorship W104393772A5054668121 @default.
• W104393772 hasAuthorship W104393772A5066769664 @default.
• W104393772 hasAuthorship W104393772A5074566771 @default.
• W104393772 hasAuthorship W104393772A5075195777 @default.
• W104393772 hasAuthorship W104393772A5079420772 @default.
• W104393772 hasAuthorship W104393772A5089784577 @default.
• W104393772 hasAuthorship W104393772A5091675945 @default.
• W104393772 hasBestOaLocation W1043937721 @default.
• W104393772 hasConcept C123576724 @default.
• W104393772 hasConcept C126322002 @default.
• W104393772 hasConcept C164705383 @default.
• W104393772 hasConcept C198710026 @default.
• W104393772 hasConcept C203092338 @default.
• W104393772 hasConcept C2775915353 @default.
• W104393772 hasConcept C2778198053 @default.
• W104393772 hasConcept C2908929049 @default.
• W104393772 hasConcept C535046627 @default.
• W104393772 hasConcept C71924100 @default.
• W104393772 hasConcept C84393581 @default.
• W104393772 hasConcept C98274493 @default.

• next